SBMFF — Sino Biopharmaceutical Limited/ADR

—
OTC · Unknown · Unknown · CIK 1604982 ·
Last close
$0.67
Market Cap
$11.85B
52W High
$0.88
52W Low
$0.59
ADV30
13
Next earnings
2026-08-19

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — 83,207,720,000 14,882,137,000 36,963,005,000
Dec 2025 — — — — 76,009,821,000 12,180,729,000 33,923,894,000
Jun 2025 — — — — 74,894,406,000 11,103,702,000 29,116,691,000

Balance + Analyst (yfinance extras)

Retained Earnings
$27,605,714,000
Inventory
$1,968,246,000
Receivables
—
ST Investments
$12,695,322,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$33,704,073,216
EBITDA
$10,410,426,368
Free Cash Flow
$6,601,288,704
Enterprise Value
$15,759,328,256
Total Cash
$27,577,458,688
Total Debt
$17,171,440,640
Shares Out
17,818,952,537
Trailing EPS
$0.02
Book Value
$0.25
ROE
14.1%
ROA
7.5%
Div Yield
2.19%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 31,834,488,000 6,899,933,000 2,343,348,000 76,009,821,000 33,923,894,000 30,670,958,000 9,291,821,000
Dec 2024 28,866,159,000 6,334,492,000 3,499,834,000 65,408,069,000 22,633,999,000 31,960,789,000 6,615,120,000
Dec 2023 26,199,409,000 6,086,401,000 2,331,939,000 63,604,819,000 25,434,866,000 30,474,469,000 6,065,734,000
Dec 2022 26,026,164,000 5,479,804,000 2,543,570,000 64,064,284,000 26,120,736,000 29,747,035,000 6,265,155,000

Peers — same industry

TickerNameMarket CapLastDaily %
RTO RENTOKIL INITIAL PLC /FI $11.86B $23.56 —
NYT NEW YORK TIMES CO $11.75B $73.82 —
DLAKY DEUTSCHE LUFTHANSA A G /FI $11.64B $9.68 —
IT GARTNER INC $11.57B $183.47 —
COO COOPER COMPANIES, INC. $11.55B $60.72 —

News headlines (Yahoo Finance, 1h cache)

Sino Biopharmaceutical (SEHK:1177) Stock Looks Overvalued On Earnings Today
2026-11-10 20:13 · Yahoo
China’s burgeoning novel medicines success presents opportunity for Europe
2026-11-10 11:41 · Yahoo
Boehringer signs oncology deal with Sino Biopharm worth up to $7.4bn
2026-11-04 12:39 · Yahoo
Boehringer Ingelheim and SBP Group enter partnership to advance next-generation cancer therapies
2026-11-04 08:40 · Yahoo
Sino Biopharmaceutical (SEHK:1177) Could Be 71% Below Fair Value Following Phase III Enrollment Update
2026-10-28 22:08 · Yahoo
Sino Biopharmaceutical (SEHK:1177) Stock Looks Expensive On Its Current Earnings
2026-10-20 18:09 · Yahoo
Transcenta Therapeutics Announces Appointment of Ms. Jennie Ma as Chief Financial Officer
2026-10-19 12:00 · Yahoo
Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion
2026-08-19 11:45 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.